eosine yellowish-(ys) has been researched along with Diabetes Mellitus, Type 2 in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 9 (90.00) | 2.80 |
| Authors | Studies |
|---|---|
| An, Y; Dong, Q; Liu, J; Su, J; Sun, B; Wang, J; Xie, H | 1 |
| Cheng, S; Liu, J; Liu, X; Liu, Y; Lu, J; Tang, Q; Xiang, M; Yuan, X; Zhang, L; Zhang, Y; Zhu, S | 1 |
| Chen, J; Hao, L; Huang, L; Li, J; Wang, M; Yue, Y; Zuo, Y | 1 |
| Ishijima, T; Iswara, A; Mukai, K; Nakajima, Y; Nakano, Y; Nakatani, T; Oe, M; Okuwa, M; Sugama, J; Tanaka, K; Tanaka, Y | 1 |
| Bei, W; Chen, X; Guo, J; Hu, X; Liang, M; Lin, Q; Wang, H; Wang, K; Wang, L; Wang, W; Yin, J; Zhang, X; Zhong, Q | 1 |
| Bao, W; Cao, L; Fan, Y; Sun, H; Wu, X; Xu, J; Zhang, H | 1 |
| Huang, X; Kong, J; Li, X; Wang, X; Wu, H; Xu, F; Yang, X; Yu, P; Zhang, L; Zhen, C | 1 |
| Loupa, C; Manes, C; Meimeti, E; Miriagou, V; Mostratos, D; Provatopoulou, X; Rallis, M; Roussis, V; Tentolouris, N; Tzouvelekis, L; Vitsos, A | 1 |
| Birnbaum, Y; Chen, H; Nylander, S; Tran, D; Ye, Y | 1 |
| An, F; Jin, T; Liu, D; Liu, H; Liu, M; Lu, L; Pan, J; Tian, J; Wang, X; Zhang, M | 1 |
1 trial(s) available for eosine yellowish-(ys) and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Ointments containing Ceratothoa oestroides extract: Evaluation of their healing potential in the treatment of diabetic foot ulcers.
Topics: Aged; Animals; Anti-Bacterial Agents; Cefaclor; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Foot; Eosine Yellowish-(YS); Escherichia coli; Female; Humans; Isopoda; Klebsiella pneumoniae; Male; Middle Aged; Ointments; Olive Oil; Staphylococcus aureus; Tissue Extracts; Treatment Outcome; Water Loss, Insensible; Wound Healing | 2020 |
9 other study(ies) available for eosine yellowish-(ys) and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
The Influence of Heparan Sulfate on Breast Amyloidosis and the Toxicity of the Pre-fibrils Formed by β-casein.
Topics: Amyloid; Amyloidosis; Animals; Caseins; Diabetes Mellitus, Type 2; Eosine Yellowish-(YS); Fibrosis; Hematoxylin; Heparitin Sulfate; Inflammation; Rats | 2022 |
Exercise and Metformin Intervention Prevents Lipotoxicity-Induced Hepatocyte Apoptosis by Alleviating Oxidative and ER Stress and Activating the AMPK/Nrf2/HO-1 Signaling Pathway in db/db Mice.
Topics: AMP-Activated Protein Kinases; Animals; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Blood Glucose; Caspase 3; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Endoplasmic Reticulum Stress; Eosine Yellowish-(YS); Hematoxylin; Hepatocytes; Hypoglycemic Agents; Lipids; Metformin; Mice; NF-E2-Related Factor 2; Oxidative Stress; Signal Transduction; Superoxide Dismutase-1 | 2022 |
Implications of lysyl oxidase-like protein 3 expression in the periodontium of diabetic rats.
Topics: Amino Acid Oxidoreductases; Animals; Collagen; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Eosine Yellowish-(YS); Hematoxylin; Periodontal Diseases; Periodontal Ligament; Periodontium; Protein-Lysine 6-Oxidase; Rats; Rats, Zucker | 2022 |
Wound healing in db/db mice with type 2 diabetes using non-contact exposure with an argon non-thermal atmospheric pressure plasma jet device.
Topics: Animals; Argon; Blood Glucose; Colloids; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Eosine Yellowish-(YS); Hematoxylin; Hydrogen Peroxide; Male; Mice; Mice, Inbred C57BL; Nitrogen; Oxygen; Plasma Gases; Wound Healing | 2022 |
Fufang-zhenzhu-tiaozhi formula protects islet against injury and promotes β cell regeneration in diabetic mice.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Eosine Yellowish-(YS); Hematoxylin; Insulin; Islets of Langerhans; Metformin; Mice; Mice, Inbred C57BL; Proliferating Cell Nuclear Antigen; Regeneration | 2023 |
Exploring Anti-Type 2 Diabetes Mellitus Mechanism of Gegen Qinlian Decoction by Network Pharmacology and Experimental Validation.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Drugs, Chinese Herbal; Eosine Yellowish-(YS); Hematoxylin; Hypoglycemic Agents; Insulin; Interleukin-17; Lipids; Mice; Network Pharmacology; NF-kappa B; RNA, Messenger; Saline Solution; Streptozocin; Tumor Necrosis Factor-alpha | 2022 |
Lupenone improves type 2 diabetic nephropathy by regulating NF-κB pathway-mediated inflammation and TGF-β1/Smad/CTGF-associated fibrosis.
Topics: Animals; Anti-Inflammatory Agents; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Eosine Yellowish-(YS); Fibrosis; Hematoxylin; Inflammation; Kidney; Mice; NF-kappa B; Proteinuria; Rats; Transforming Growth Factor beta1 | 2023 |
Ticagrelor and Dapagliflozin Have Additive Effects in Ameliorating Diabetic Nephropathy in Mice with Type-2 Diabetes Mellitus.
Topics: Albumins; AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents; Benzhydryl Compounds; Creatinine; Cystatin C; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Eosine Yellowish-(YS); Glucose; Glucosides; Hematoxylin; Inflammasomes; Insulins; Kidney; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Periodic Acid; Proto-Oncogene Proteins c-akt; Ticagrelor | 2022 |
AIM2 gene silencing attenuates diabetic cardiomyopathy in type 2 diabetic rat model.
Topics: Animals; Apoptosis; CARD Signaling Adaptor Proteins; Caspase 1; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Disease Models, Animal; DNA-Binding Proteins; Eosine Yellowish-(YS); Female; Gene Silencing; Hematoxylin; Interleukin-1beta; Male; Myocardium; Myocytes, Cardiac; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; RNA, Small Interfering | 2019 |